Evidence map›Paper›PMID 38392856›Full record

ReviewPathogens (Basel, Switzerland)2024

John E Markantonis, John T Fallon, Rajat Madan, Md Zahidul Alam

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Outcomes of Clostridium difficile infection in liver transplant patients: A systematic review and meta-analysis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Review
  2. Article
  3. Article
  4. Predictors of RecurrentDiagnostics (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Clinical and molecular epidemiology ofFrontiers in microbiology · 2026
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. [Clostridiodes difficile bacteraemia. First mexican case report].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  20. Therapeutics involved in managing initial and recurrentWorld journal of gastrointestinal pharmacology and therapeutics · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

John E MarkantonisDepartment of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA.ORCID 0000-0002-0774-0672
John T FallonDepartment of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA.ORCID 0000-0002-7677-4868
Rajat MadanDivision of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.ORCID 0000-0002-9821-1257
Md Zahidul AlamDepartment of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, 600 Moye Boulevard, Greenville, NC 27834, USA.

Funding

Regulation of C. difficile colitis by host genetic and immune factorsR01AI158451 · NIAID · UNIVERSITY OF CINCINNATI · PI MADAN, RAJAT · 2021 to 2025
$2.0M
Role of a common leptin receptor polymorphism in regulating neutrophil heterogeneity after C. difficile infectionI01BX004630 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI MADAN, RAJAT · 2019 to 2025
–
BLRD VA I01 BX004630NIAID NIH HHS R01 AI158451
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsClostridioides difficileClostridium InfectionsDiarrheaDrug Resistance, BacterialHumansAnti-Bacterial Agentscell cytotoxicity neutralization assayClostridioides difficile infectiondrug-resistant pathogenenzyme immunoassayshost immunitynucleic acid amplification testingrecurrent C. difficile infection

Identifiers

PMID38392856
PMCPMC10891949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.